Biomarkers of Aggressive Prostate Cancer at Diagnosis

In the United States, prostate cancer (CaP) remains the second leading cause of cancer deaths in men. CaP is predominantly indolent at diagnosis, with a small fraction (25–30%) representing an aggressive subtype (Gleason score 7–10) that is prone to metastatic progression. This fact, coupled with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Boehm, Brock E., York, Monica E., Petrovics, Gyorgy, Kohaar, Indu, Chesnut, Gregory T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916581/
https://www.ncbi.nlm.nih.gov/pubmed/36768533
http://dx.doi.org/10.3390/ijms24032185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916581/
https://www.ncbi.nlm.nih.gov/pubmed/36768533
http://dx.doi.org/10.3390/ijms24032185

Ejemplares similares